Keywords: Arenea, Eisai, Lorcaserin, Ph III data, Weight loss, Obesityy, BLOOM-DN study

Arena and Eisai say new lorcaserin Ph III data show statistically significant weight loss

Article | 11 November 2010

Arena Pharmaceuticals (Nasdaq: ARNA) and marketing partner Japanese drug major Eisai  demonstrate statistically significant weight loss in obese and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Arena Pharmaceuticals

Go to company listing

Related Drugs

lorcaserin

Go to drug listing